Tag: plant-based vaccines market growth

  • 2024-2033 Plant-Based Vaccines Market: Key Insights on Growth Opportunities

    2024-2033 Plant-Based Vaccines Market: Key Insights on Growth Opportunities

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Trajectory for the Plant-Based Vaccines Market by 2033?

    The market size of plant-based vaccines has significantly increased in the recent past. The growth is predicted to rise from $1.52 billion in 2023 to $1.68 billion in 2024, experiencing a compound annual growth rate (CAGR) of 10.4%. The expansion during the historical time frame is due to difficulties in traditional vaccine production, the requirement for cost-effective vaccine manufacturing, the advent of plant molecular farming, decreased allergen potential, and the application of synthetic biology.

    Expectations are that the plant-based vaccines market will experience swift expansion in the upcoming years, with predictions indicating a growth to $2.5 billion in 2028, demonstrating a compound annual growth rate (CAGR) of 10.4%. Factors driving this growth during the forecast period include preparedness for pandemics, worldwide health security, broader vaccine application, and acceptance within the pharmaceutical industry. Trends expected to shape this period involve advancements in plant biotechnology, commitment to environmental sustainability, and incorporation of artificial intelligence and machine learning.

    Claim Your Free Sample of the Global Plant-Based Vaccines Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12144&type=smp

    What Factors Are Leading to Growth in the plant-based vaccines Market?

    The widespread existence of infectious diseases is likely to accelerate the expansion of the plant-based vaccine market. Infectious illnesses, caused by pathogens such as bacteria, viruses, fungi, or parasites, are targeted by plant-based vaccines. These vaccines, used in both traditional and contemporary medicine for a host of diseases including infections, have the potential to provide safe, effective, stable, and cost-effective preventive measures, immunizations, and treatments. For example, the Global Tuberculosis Report by the World Health Organization, a Switzerland-based global health agency, revealed in October 2022, that the global count of tuberculosis (TB) was around 10.6 million, with a rate of 134 per 100,000 people. TB cases were primarily found in the Southeast Asia region, forming 45% of the total cases, with Africa trailing at 23%. Thus, the widespread occurrence of infectious diseases is contributing to the expansion of the plant-based vaccine market.

    Which Segments Play a Key Role in Understanding the Plant-Based Vaccines Market?

    1) By Vaccine Type: Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types

    2) By Source: Tobacco Plant, Maize, Potato, Other Sources

    3) By Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Other Applications

    What Trends Are Emerging as Game-Changers in the Plant-Based Vaccines Market?

    A primary trend starting to gain traction in the plant-based vaccine market is product innovation. Top businesses in the field are prioritizing the creation of novel products as means of maintaining their market position. A recent example of this is what occurred in February 2022, when Canada’s Medicago Inc., a biopharmaceutical firm, and UK’s GSK PLC, a prominent pharmaceutical and biotechnology organization, made the announcement that COVIFENZ, their COVID-19 vaccine, had received approval from Health Canada. It’s significant to note that COVIFENZ is the first recombinant, adjuvanted vaccine to utilize plant-based virus-like particles (VLP), specifically designed for the coronavirus. The process of COVIFENZ involves utilizing coronavirus-like particle (CoVLP) technology and consists of recombinant spike (S) glycoproteins created as virus-like particles (VLPs).

    Order Now for Fast Delivery of Your Plant-Based Vaccines Market Report!

    https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

    Which Regions Are Setting the Pace for Plant-Based Vaccines Market Growth?

    North America was the largest region in the plant-based vaccines market in 2023. The regions covered in the plant-based vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Plant-Based Vaccines Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the plant-based vaccines market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Plant-Based Vaccines Market Include

    1. Plant-Based Vaccines Market Executive Summary

    2. Plant-Based Vaccines Market Segments

    3. Plant-Based Vaccines Market Size And Template Market Growth Rate

    4. Key Plant-Based Vaccines Market Trends

    5. Major Plant-Based Vaccines Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Plant-Based Vaccines Market

    26. Top Plant-Based Vaccines Companies

    27. Plant-Based Vaccines Market Opportunities And Strategies

    28. Plant-Based Vaccines Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Veterinary Vaccines Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

    Plant-Based Feed Enzymes Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/plant-based-feed-enzymes-global-market-report

    Plant-Based Protein Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/plant-based-protein-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Top 5 Insights From The Plant-Based Vaccines Market Report 2024

    Top 5 Insights From The Plant-Based Vaccines Market Report 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Plant-Based Vaccines Global Market Report 2024, the plant-based vaccines market is expected to show promising growth in the forecast period.

    Introduction:

    The plant-based vaccines market has witnessed remarkable growth in recent years, and projections indicate a promising future trajectory. Let’s delve into the factors driving this growth and the key trends shaping the market landscape.

    Rapid Expansion in Market Size:

    • From $1.52 billion in 2023 to $1.68 billion in 2024.
    • Compound Annual Growth Rate (CAGR) of 10.4%.
    • Attributed to traditional vaccine production challenges, need for cost-effective production, emergence of plant molecular farming, reduced allergenic potential, and synthetic biology applications.

    Forecasted Growth and Contributing Factors:

    • Expected to reach $2.5 billion in 2028.
    • CAGR of 10.4%.
    • Factors include pandemic preparedness, global health security, expansion of vaccine applications, and pharmaceutical industry adoption.
    • Major trends include technological advancements, environmental sustainability, and integration of artificial intelligence and machine learning.

    View More On The Plant-Based Vaccines Market Report 2024 – https://www.thebusinessresearchcompany.com/report/plant-based-vaccines-global-market-report

    Increased Prevalence of Infectious Diseases Fuels Market Growth:

    • Infectious diseases drive demand for plant-based vaccines.
    • Plant-based vaccines offer secure, effective, stable, and reasonably priced prophylactics and medications.
    • Example: Global Tuberculosis Report highlights the high prevalence of TB cases, particularly in Southeast Asia and Africa.
    • Notable companies in the market include Sanofi Pasteur SA, GlaxoSmithKline plc., and Medicago Inc.

    Key Players Pioneering Plant-Based COVID-19 Vaccine Innovation:

    • Product innovation crucial for market sustainability.
    • Medicago Inc. and GSK PLC. introduced COVIFENZ, the first plant-based COVID-19 vaccine.
    • COVIFENZ utilizes COVID-19-like particle (CoVLP) technology, showcasing the potential of plant-based vaccines in combating global health crises.

    Market Segmentation:

    • Vaccine Types: Bacterial, Viral, Parasite, Others.
    • Source: Tobacco Plant, Maize, Potato, Others.
    • Application: Influenza, Zika Virus, Ebola Virus, Poultry Disease, Others.
    • North America led the market in 2023.

    Conclusion: The plant-based vaccines market is on a robust growth trajectory, driven by factors such as the need for innovative vaccine solutions, increasing prevalence of infectious diseases, and advancements in biotechnology. With key players pioneering vaccine innovation and expanding market segments, the future looks promising for plant-based vaccines in addressing global health challenges.

    Request A Sample Of The Global Plant-Based Vaccines Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12144&type=smp